Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2008-02-13

FDA Approved: EMSAM — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for EMSAM (selegiline transdermal patch) from Viatris Specialty LLC. This action updates the product labeling for EM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EMSAM (selegiline)

Snippet

SUPPL AP for EMSAM (SELEGILINE)